RxSight Inc (NAS:RXST)
$ 56.45 2.12 (3.9%) Market Cap: 2.24 Bil Enterprise Value: 2.02 Bil PE Ratio: 0 PB Ratio: 8.13 GF Score: 58/100

Q3 2022 Rxsight Inc Earnings Call Transcript

Nov 07, 2022 / 09:30PM GMT
Release Date Price: $12.62 (+7.86%)
Operator

Hello, and thank you for standing by. Welcome to the RxSight Third Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I'd like to now hand the conference over to your speaker today, Alex Huang, Associate Director of Investor Relations.

Alex Huang;AssociateDirectorInvestorRelations

Thank you, operator. Presenting today are President and Chief Executive Officer of RxSight, Ron Kurtz; and Chief Financial Officer, Shelley Thunen. Earlier today, RxSight released financial results for the 3 and 9 months ended September 30, 2022. A copy of the press release is available on the company's website.

Before we begin, I would like to inform you that comments and responses to questions during today's call reflect management's views as of today, November 7, 2022, and will include forward-looking and opinion statements, including predictions, estimates, plans, expectations and other information. Actual results may differ materially from those expressed or implied as a result

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot